A wonderful breakthrough for scientists from the universities of Würzburg and Stony Brook (USA): they have shed light on the binding and action mechanisms of two new inhibitors that attack the plague pathogen, the bacterium Yersinia pestis. In the current issue of the journal “Structure” they present both substances, which belong to the pyridone group.
A newly developed inhibitor (magenta) from the pyridone group binds to a vital enzyme of the plague pathogen. The cofactor of the enzyme, NADH, which contributes significantly to the effect of the inhibitor, is shown in blue.
Image: Maria Hirschbeck
The new inhibitors attach themselves to the bacterial enzyme FabV and impede it in its work. This enzyme performs the final step in the production of bacterial fatty acids. If it is blocked, the plague pathogen dies. This is because without fatty acids it cannot maintain its protective shell, the cell membrane.
“But the two substances do not inhibit the enzyme well enough yet,” says Professor Caroline Kisker of the Rudolf Virchow Center at the University of Würzburg. For that reason, these new inhibitors and their interactions with the enzyme now need to be analyzed further and improved.
Steps to improve the inhibitors
Structural biologist Kisker, her doctoral student Maria Hirschbeck, and postdoctoral fellow Jochen Kuper are collaborating on this with Würzburg chemists and pharmacists Professor Christoph Sotriffer and Steffen Wagner as well as with Peter Tonge of Stony Brook University. In their laboratories, these scientists are working not with pathogens of the plague, but with the isolated enzyme. They are crystallizing it as a compound with the inhibitors, rendering it into a state in which they can analyze how the inhibitors attach themselves to the enzyme right down to the molecular level.
Christoph Sotriffer, an expert in computer modeling of molecules, and his staff then examine the crystal structures and propose changes to the inhibitors that might make these even more effective. Finally, the modified inhibitors are synthesized and re-tested: test-tube experiments reveal whether they really are further weakening this enzyme that is so vital to the plague pathogen.
“This cycle will generally have to be repeated several times until, ideally, we end up with a highly active inhibitor,” says Caroline Kisker. However, whether the inhibitor will then also be suitable as medication is far from certain. Numerous other tests will be needed to determine that.
This research is contained within the Würzburg Collaborative Research Center 630 (Recognition, Preparation, and Functional Analysis of Agents against Infectious Diseases). The German Research Foundation (DFG) is funding the work.
Progression of an infection with the plague pathogen
The pathogens of the plague tend to live in rodents, particularly rats. They can be transferred to humans through bites from infected rat fleas. After one to seven days, the sufferer develops a high fever and shivering, among other things. These symptoms are joined by painful buboes, swellings of the lymph nodes that appear like lumps on the skin. In rare cases, the lumps rupture outwards, according to the Robert Koch Institute.
As the disease progresses, the pathogens may also attack internal organs, especially the lungs. It is then common for the sufferer to cough up blood. At this stage, the pathogens can also be transmitted from human to human in droplets of coughed-up fluid. Without treatment with antibiotics, this pneumonic plague, as it is known, almost always ends in death. With bubonic plague, on the other hand, there is a 50 percent chance of survival even without treatment. Generally speaking, if the plague is detected early, it can be treated successfully with antibiotics – provided that these are still effective.
Resistant plague pathogens discovered
In 2010, scientists from the Pasteur Institute in Paris found two plague pathogen strains that no longer respond to antibiotics. Both came from Madagascar. This island south-east of Africa is a hotspot for global outbreaks of the plague: in 2010, there were 313 recognized cases of the disease here, according to statistics from the World Health Organization (WHO). The second-highest incidence of infection was found in the Congo (152), followed by Peru with 27 cases.
“Structure of the Yersinia pestis FabV Enoyl-ACP Reductase and its Interaction with two 2-Pyridone Inhibitors”, Maria W. Hirschbeck, Jochen Kuper, Hao Lu, Nina Liu, Carla Neckles, Sonam Shah, Steffen Wagner, Christoph A. Sotriffer, Peter J. Tonge, and Caroline Kisker. Structure, Vol. 20, Issue 1, 89-100, 11 January 2012, DOI 10.1016/j.str.2011.07.019
Prof. Dr. Caroline Kisker, Institute of Structural Biology, Rudolf Virchow Center / DFG Research Center for Experimental Biomedicine, T +49 (0)931 31-80381, email@example.com
Robert Emmerich | Julius-Maximilians-Universität W
Repairing damaged hearts with self-healing heart cells
22.08.2017 | National University Health System
Biochemical 'fingerprints' reveal diabetes progression
22.08.2017 | Umea University
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
22.08.2017 | Health and Medicine
22.08.2017 | Materials Sciences
22.08.2017 | Life Sciences